TREATMENT OF ISOLATED INTRACRANIAL PROGRESSION OF LUNG CANCER DURING TREATMENT WITH SYSTEMIC EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS (EGFR-TKIs)

Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are an effective treatment for non-small-cell lung cancer (NSCLC) harbouring EGFR mutations. The development of isolated central nervous system (CNS) metastases is a relevant clinical problem in patients who resp...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Amanda Tufman, Kathrin Schrödl, Heike Scheithauer, Thomas Duell, Eva Coppenrath, Rudolf Maria Huber
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	European Medical Journal 2015-05-01
Schriftenreihe:	European Medical Journal Respiratory
Schlagworte:	lung cancer targeted therapy tyrosine kinase inhibitor brain metastases
Online-Zugang:	https://emj.emg-health.com/wp-content/uploads/sites/2/2018/02/Treatment-of-Isolated-Intracranial-Progression-of-Lung-Cancer-During-Treatment-with-Systemic-Epidermal-Growth-Factor-Receptor-Tyrosine-Kinase-Inhibitors-EGFR-TKIs.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!